Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDER'S EQUITY - USD ($)
$ in Thousands
Total
At The Market
Common Stock
Common Stock
At The Market
Additional Paid-In Capital
Additional Paid-In Capital
At The Market
Accumulated Other Comprehensive Gain (Loss)
Accumulated Deficit
Balance at Dec. 31, 2020 $ 90,553   $ 56   $ 467,518     $ (377,021)
Balance (in shares) at Dec. 31, 2020     56,222,746          
Exercise of stock options 157       157      
Exercise of stock options, Shares     20,134          
Vesting of restricted stock units     206,762          
Stock-based compensation expense 2,930       2,930      
Issuance of common stock at-the-market, net of issuance costs   $ 70,468   $ 5   $ 70,463    
Issuance of common stock at-the-market, net of issuance costs,Shares       5,400,000        
Net loss (14,228)             (14,228)
Balance at Mar. 31, 2021 149,880   $ 61   541,068     (391,249)
Balance (in shares) at Mar. 31, 2021     61,849,642          
Balance at Dec. 31, 2020 90,553   $ 56   467,518     (377,021)
Balance (in shares) at Dec. 31, 2020     56,222,746          
Net loss (86,600)              
Balance at Dec. 31, 2021 $ 85,218   $ 61   548,815   $ (79) (463,579)
Balance (in shares) at Dec. 31, 2021 62,024,035   62,024,035          
Exercise of stock options $ 1       1      
Exercise of stock options, Shares 37,700   37,700          
Vesting of restricted stock units     739,561          
Stock-based compensation expense $ 2,863       2,863      
Other comprehensive loss (194)           (194)  
Net loss (25,146)             (25,146)
Balance at Mar. 31, 2022 $ 62,742   $ 61   $ 551,679   $ (273) $ (488,725)
Balance (in shares) at Mar. 31, 2022 62,801,296   62,801,296